Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
OCLS [NASD]
Oculus Innovative Sciences, Inc.
Index- P/E- EPS (ttm)-1.00 Insider Own8.78% Shs Outstand7.23M Perf Week-13.59%
Market Cap24.37M Forward P/E- EPS next Y-0.38 Insider Trans3.21% Shs Float7.03M Perf Month-42.29%
Income-6.20M PEG- EPS next Q-0.21 Inst Own21.50% Short Float12.46% Perf Quarter-4.26%
Sales14.10M P/S1.73 EPS this Y30.50% Inst Trans0.06% Short Ratio2.28 Perf Half Y37.55%
Book/sh0.50 P/B6.74 EPS next Y25.50% ROA-58.20% Target Price9.00 Perf Year-19.76%
Cash/sh0.47 P/C7.17 EPS next 5Y- ROE-208.50% 52W Range2.20 - 7.21 Perf YTD-3.16%
Dividend- P/FCF- EPS past 5Y35.00% ROI-54.10% 52W High-53.26% Beta2.00
Dividend %- Quick Ratio1.30 Sales past 5Y32.50% Gross Margin65.20% 52W Low53.18% ATR0.36
Employees41 Current Ratio1.50 Sales Q/Q-5.70% Oper. Margin-37.60% RSI (14)39.55 Volatility7.24% 8.80%
OptionableNo Debt/Eq0.00 EPS Q/Q75.70% Profit Margin-43.30% Rel Volume0.26 Prev Close3.42
ShortableYes LT Debt/Eq0.00 EarningsNov 19 AMC Payout- Avg Volume383.74K Price3.37
Recom1.50 SMA20-19.78% SMA50-13.63% SMA2006.26% Volume99,476 Change-1.46%
19-Apr-13Reiterated Maxim Group Buy $2.80 → $6
14-Dec-10Initiated Rodman & Renshaw Mkt Outperform $3
18-Aug-09Initiated Dawson James Buy $4.50
07-Nov-08Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
06-Aug-08Reiterated Rodman & Renshaw Mkt Outperform $14 → $12
11-Apr-08Reiterated Rodman & Renshaw Mkt Outperform $16 → $14
18-Jul-07Reiterated Rodman & Renshaw Mkt Outperform $13 → $16
21-Jun-07Initiated Rodman & Renshaw Mkt Outperform $13
27-Mar-07Initiated Roth Capital Buy $10
09-Apr-14 08:08AM  Oculus Innovative Sciences Receives 'Strong Consensus' Rating for Use With Kinetic Concepts' Negative Pressure Wound Therapy With Instillation GlobeNewswire
02-Apr-14 04:55PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
08:08AM  Oculus Innovative Sciences Announces Board of Directors Restructuring Following Ruthigen IPO GlobeNewswire
01-Apr-14 05:05PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financi EDGAR Online +7.16%
27-Mar-14 08:20AM  Oculus appoints Cytokinetics CFO Sharon Barbari to board at theflyonthewall.com -9.19%
08:08AM  Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors GlobeNewswire
26-Mar-14 02:42PM  Why Oculus Innovative Sciences (OCLS) Stock Is Up Today at TheStreet +5.51%
02:36PM  Oculus strength attributed to confusion over Facebook acquisition at theflyonthewall.com
02:16PM  Midday movers: King Digital, Garmin, Corning & More at CNBC
12:52PM  A case of mistaken identity sends another Oculus soaring at MarketWatch
12:41PM  What's in the name Oculus? at Financial Times
12:19PM  On The Fly: Midday Wrap at theflyonthewall.com
12:02PM  Whoops! Stocks with Oculus name spike at CNNMoney.com
12:00PM  [video] Tech Yeah! Facebook moves into virtual reality at CNBC
11:30AM  Oculus Shares Up 152%, But It's Not That Oculus at The Wall Street Journal
11:25AM  Virtual Confusion: Unrelated Oculus Companies Rally on Facebook Buy at Fox Business
11:15AM  Oops! Wrong Oculus shares skyrocket at CNBC
10:49AM  Oculus strength attributed to confusion over Facebook acquisition at theflyonthewall.com
10:06AM  Two Stocks That Sound Like Oculus Are Going Bonkers For Some Reason Business Insider
25-Mar-14 05:06PM  [video] Facebook acquires Oculus for $2 billion at CNBC -6.78%
21-Mar-14 06:03PM  Nasdaq stocks posting largest percentage decreases AP -11.99%
01:24PM  Nasdaq stocks posting largest percentage decreases AP
17-Mar-14 01:09PM  Why Oculus Could Trade Higher Within 2 Weeks at Seeking Alpha +12.84%
14-Mar-14 01:25PM  5 Stocks Poised for Breakouts at TheStreet +9.27%
01:25PM  5 Stocks Poised for Breakouts
27-Feb-14 08:08AM  Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors GlobeNewswire +9.27%
26-Feb-14 04:31PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors EDGAR Online
21-Feb-14 10:00PM  Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering GlobeNewswire +9.37%
01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials
19-Feb-14 08:16AM  Oculus receives approval for oral, throat infection products in Mexico theflyonthewall.com +20.63%
08:16AM  Oculus receives approval for oral, throat infection products in Mexico
08:08AM  Oculus Innovative Sciences Receives Approval for Oral and Throat Infection Products in Mexico GlobeNewswire
14-Feb-14 04:34PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
13-Feb-14 04:37PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:25PM  Oculus Innovative Sciences, Inc. Discusses Q3 2014 Results (Webcast) at Seeking Alpha
04:25PM  Oculus Innovative Sciences, Inc. Discusses Q3 2014 Results (Webcast)
04:05PM  Oculus Innovative Sciences Reports Revenues of $3.3 Million for Third Quarter of Fiscal 2014 GlobeNewswire
06-Feb-14 04:39PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors EDGAR Online
04:05PM  Oculus Innovative Sciences Announces Completion of Agreements Required for IPO by Company's Subsidiary, Ruthigen, Inc. GlobeNewswire
04-Feb-14 09:13AM  Story Stocks from Briefing.com Briefing.com
08:08AM  Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne GlobeNewswire
30-Jan-14 08:08AM  Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call GlobeNewswire
08:08AM  Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call
07-Jan-14 08:08AM  Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market GlobeNewswire +8.66%
08:08AM  Oculus Innovative Sciences Introduces Two New Microcyn(R) Advanced Wound Care Products for U.S. Prescription Wound Care Market
30-Dec-13 08:08AM  Oculus Innovative Sciences Receives Notification of Compliance With the Stockholders' Requirement of the NASDAQ Listing Rules GlobeNewswire
08:08AM  Oculus Innovative Sciences Receives Notification of Compliance With the Stockholders' Requirement of the NASDAQ Listing Rules
19-Dec-13 08:08AM  Oculus Innovative Sciences Pays Off Debt to Strengthen Balance Sheet; Obtains $4.5 Million in Stockholders' Equity on a Pro Forma Basis as of September 30, 2013, Sufficient to Regain Compliance with NASDAQ Listing Rules GlobeNewswire
08:08AM  Oculus Innovative Sciences Pays Off Debt to Strengthen Balance Sheet; Obtains $4.5 Million in Stockholders' Equity on a Pro Forma Basis as of September 30, 2013, Sufficient to Regain Compliance with NASDAQ Listing Rules
18-Dec-13 08:39AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru EDGAR Online
08:39AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
17-Dec-13 08:08AM  NVN Therapeutics Launches New Tropical Flavor Glucorein(TM) Medical Food for Dietary Management of Polycystic Ovary Syndrome (PCOS) GlobeNewswire -5.66%
08:08AM  NVN Therapeutics Launches New Tropical Flavor Glucorein(TM) Medical Food for Dietary Management of Polycystic Ovary Syndrome (PCOS)
16-Dec-13 08:18AM  Ampio's Failed Drug Partner Talks Forces Spin-Out Plan at TheStreet
08:18AM  Ampio's Failed Drug Partner Talks Forces Spin-Out Plan
12-Dec-13 08:08AM  Oculus Innovative Sciences Receives Mexican Ministry of Health Approval of Microcyn(R)-Based Hydrogel for Management of Scars GlobeNewswire
08:08AM  Oculus Innovative Sciences Receives Mexican Ministry of Health Approval of Microcyn(R)-Based Hydrogel for Management of Scars
06-Dec-13 04:33PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online
04:33PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
05-Dec-13 03:40PM  Oculus Gains on Scar Product Approval Zacks -12.03%
03:40PM  Oculus Gains on Scar Product Approval
02:24AM  InPlay: Oculus Innovative Sciences announces $2.2 mln securities offering; includes 550K shares at $4.00 per share with no warrant coverage Briefing.com
04-Dec-13 11:00PM  Oculus Innovative Sciences, Inc. Announces $2.2 Million Securities Offering GlobeNewswire +103.43%
11:00PM  Oculus Innovative Sciences, Inc. Announces $2.2 Million Securities Offering
06:02PM  Nasdaq stocks posting largest percentage increases AP
01:24PM  Nasdaq stocks posting largest percentage increases AP
12:41PM  Midday movers: Las Vegas Sands, Deere, GM & more at CNBC
08:11AM  InPlay: Oculus Innovative Sciences receives FDA clearance for Microcyn Scar Management HydroGel; Oculus U.S dermatology partner, Quinnova Pharmaceuticals, targeting U.S. launch in Q2 2014 Briefing.com
08:08AM  Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R) Scar Management HydroGel GlobeNewswire
27-Nov-13 04:34PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru EDGAR Online
26-Nov-13 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials
19-Nov-13 11:11PM  Oculus Innovative Sciences CEO Discusses F2Q2014 Results - Earnings Call Transcript at Seeking Alpha
04:10PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online
04:05PM  Oculus Innovative Sciences Reports Revenues of $4.1 Million for Second Quarter of Fiscal 2014, Meeting Guidance of Greater Than $3.6 Million GlobeNewswire
03:31PM  Notable companies reporting after market close at theflyonthewall.com
07:07AM  Q2 2014 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close CCBN
05-Nov-13 08:08AM  Oculus Innovative Sciences Announces Fiscal Second Quarter 2014 Financial Results and Conference Call GlobeNewswire
24-Sep-13 04:33PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online
04:32PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
17-Sep-13 04:31PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
05-Sep-13 09:20AM  5 Stocks Under $10 Making Big Moves at TheStreet
21-Aug-13 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials
14-Aug-13 05:50PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online -5.28%
09-Aug-13 07:42PM  Oculus Innovative Sciences' CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
08-Aug-13 04:36PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operation EDGAR Online +8.50%
04:05PM  Oculus Innovative Sciences Reports Revenues of $3.4 Million for First Quarter of Fiscal 2014 GlobeNewswire
09:45AM  Is ExamWorks A Scam? at Seeking Alpha
07:07AM  Q1 2014 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close CCBN
05-Aug-13 05:09PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
31-Jul-13 08:08AM  Oculus Innovative Sciences Announces Fiscal First Quarter 2014 Financial Results and Conference Call GlobeNewswire
02-Jul-13 08:22AM  Oculus announces allowance of patent for novel surgical solution at theflyonthewall.com
08:09AM  InPlay: Oculus Innovative Sciences announces allowance of new patent in Mexico for Novel Solution for use in invasive surgical procedures Briefing.com
08:08AM  Oculus Innovative Sciences Announces Allowance of New Patent in Mexico for Novel Solution for Use in Invasive Surgical Procedures GlobeNewswire
29-Jun-13 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials EDGAR Online Financials
25-Jun-13 09:34AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online
18-Jun-13 08:25AM  Revisiting Oculus: Earnings Do Little To Ease The Pain at Seeking Alpha
13-Jun-13 08:30PM  Oculus Innovative Sciences Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
04:05PM  Oculus Innovative Sciences Reports Revenues of $15.5 Million for Fiscal Year 2013, Product Revenue Up 23 Percent GlobeNewswire
09:39AM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:07AM  Q4 2013 OCULUS INNOVATIVE SCIENCES INC Earnings Release - After Market Close CCBN
Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and non-prescription products based on its Microcyn platform technology for the dermatology, surgical, advanced wound and tissue care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. The Microcyn platform technology is based on electrically charged oxychlorine small molecules that target a range of organisms that cause disease, which include viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human advanced wound and skin care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand. The company also offers Glucorein Green Tea with chlorogenic acid, a medical food for the dietary management of glucose levels in pre-diabetics and type 2 diabetics. Its Microcyn has received seven 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, the company provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. It sells its products to hospitals, physicians, nurses, and other healthcare practitioners, as well as to dermatologists. Oculus sells its products directly, as well as through contract sales organization and distributors. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is based in Petaluma, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schutz James JChief Executive OfficerAug 16Buy2.355,10011,98514,600Aug 19 04:31 PM